Mass spectrometry and redox proteomics: Applications in disease

Mass Spectrometry Reviews

Volumn 33, Issue 4, 2014, Pages 277-301

  Butterfield, D Allan ^a   Gu, Liqing ^b   Domenico, Fabio Di ^a,c   Robinson, Renã A S ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

oxidative PTMs; protein carbonyls; protein nitration; proteomics; redox proteomics; review

Indexed keywords

ACETYLATION; AMINO ACIDS; DISEASES; FATTY ACIDS; GLYCOSYLATION; MASS SPECTROMETRY; MOLECULAR BIOLOGY; NITRATION; REVIEWS;

ADVANCED GLYCATION PRODUCT; NEURODEGENERATIVE DISORDERS; OXIDATIVE PTMS; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN CARBONYLS; PROTEIN NITRATION; PROTEOMICS; REACTIVE OXYGEN AND NITROGEN SPECIES;

PROTEINS;

3-NITROTYROSINE; 4-HYDROXY-2-NONENAL; ADVANCED GLYCATION END PRODUCT; ALDEHYDE; BIOLOGICAL MARKER; FREE RADICAL; GLUTATHIONE; PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TYROSINE;

AGING; AMINO ACID SEQUENCE; ANALOGS AND DERIVATIVES; ANIMAL; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; CHEMISTRY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG EFFECTS; HUMAN; KIDNEY DISEASE; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NITROSATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROCEDURES; PROTEIN CARBONYLATION; PROTEIN PROCESSING; PROTEOMICS; RADIATION RESPONSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGING; ALDEHYDES; AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FREE RADICALS; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY DISEASES; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEOPLASMS; NEURODEGENERATIVE DISEASES; NITROSATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 84902361638     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21374     Document Type: Article

References (209)

1. Abe K, Pan LH, Watanabe M, Kato T, Itoyama Y,. 1995. Induction of nitrotyrosine-like immunoreactivity in the lower motor-neuron of amyotrophic-lateral-sclerosis. Neurosci Lett 199: 152-154.
2. Abello N, Barroso B, Kerstjens HA, Postma DS, Bischoff R,. 2010. Chemical labeling and enrichment of nitrotyrosine-containing peptides. Talanta 80: 1503-1512.
3. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, Halliwell B,. 1997. Oxidative DNA damage in the Parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203.
4. Aluise CD, Robinson RA, Cai J, Pierce WM, Markesbery WR, Butterfield DA,. 2011. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: Insights into memory loss in MCI. J Alzheimers Dis 23: 257-269.
5. Amblard F, Cho JH, Schinazi RF,. 2009. Cu(I)-catalyzed Huisgen azide-alkyne 1,3-dipolar cycloaddition reaction in nucleoside, nucleotide, and oligonucleotide chemistry. Chem Rev 109: 4207-4220.
6. Andersen PM,. 2000. Genetic factors in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (Suppl. 1): S31-S42.
7. Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, Friedlich A, Browne SE, Schilling G, Borchelt DR, Hersch SM, Ross CA, Beal MF,. 2001. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. Neurobiol Dis 8: 479-491.
8. Andreoli R, Manini P, Corradi M, Mutti A, Niessen WM,. 2003. Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 17: 637-645.
9. Arbuzova S, Hutchin T, Cuckle H,. 2002. Mitochondrial dysfunction and Down's syndrome. BioEssays 24: 681-684.
10. Barjaktarovic Z, Schmaltz D, Shyla A, Azimzadeh O, Schulz S, Haagen J, Dorr W, Sarioglu H, Schafer A, Atkinson MJ, Zischka H, Tapio S,. 2011. Radiation-induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to X-rays. PLoS ONE 6: e27811.
11. Baynes JW,. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
12. Beal MF, Ferrante RJ,. 2004. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat Rev Neurosci 5: 373-384.
13. Behl C,. 1997. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290: 471-480.
14. Berlett BS, Stadtman ER,. 1997. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272: 20313-20316.
15. Bollineni RC, Fedorova M, Hoffmann R,. 2011. Identification of carbonylated peptides by tandem mass spectrometry using a precursor ion-like scan in negative ion mode. J Proteomics 74: 2351-2359.
16. Boyd-Kimball D, Castegna A, Sultana R, Poon HF, Petroze R, Lynn BC, Klein JB, Butterfield DA,. 2005. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: Implications for Alzheimer's disease. Brain Res 1044: 206-215.
17. Boyd-Kimball D, Poon HF, Lynn BC, Cai J, Pierce WM, Jr., Klein JB, Ferguson J, Link CD, Butterfield DA,. 2006. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): Implications for Alzheimer's disease. Neurobiol Aging 27: 1239-1249.
18. Brioschi M, Polvani G, Fratto P, Parolari A, Agostoni P, Tremoli E, Banfi C,. 2012. Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: Implications for protein function. PLoS ONE 7: e35841.
19. Butterfield DA,. 2006. Oxidative stress in neurodegenerative disorders. Antioxid Redox Signal 8: 1971-1973.
20. Butterfield DA, Kanski J,. 2001. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122: 945-962.
21. Butterfield DA, Lauderback CM,. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32: 1050-1060.
22. Butterfield DA, Stadtman ER,. 1997. Protein Oxidation processes in aging brain. Adv Cell Aging Gerontol 2: 161-191.
23. Butterfield DA, Sultana R,. 2007. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: Insights into the progression of this dementing disorder. J Alzheimers Dis 12: 61-72.
24. Butterfield DA, Sultana R,. 2008. Redox proteomics: Understanding oxidative stress in the progression of age-related neurodegenerative disorders. Expert Rev Proteomics 5: 157-160.
25. Butterfield DA, Abdul HM, Newman S, Reed T,. 2006a. Redox proteomics in some age-related neurodegenerative disorders or models thereof. NeuroRx 3: 344-357.
26. Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R,. 2006b. Pin1 in Alzheimer's disease. J Neurochem 98: 1697-1706.
27. Butterfield DA, Galvan V, Lange MB, Tang H, Sowell RA, Spilman P, Fombonne J, Gorostiza O, Zhang J, Sultana R, Bredesen DE,. 2010. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radic Biol Med 48: 136-144.
28. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R,. 2012. Redox proteomics in selected neurodegenerative disorders: From its infancy to future applications. Antioxid Redox Signal 17: 1610-1655.
29. Carney JM, Starke-Reed PE, Oliver CN, Landum RW, Cheng MS, Wu JF, Floyd RA,. 1991. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci USA 88: 3633-3636.
30. Casoni F, Basso M, Massignan T, Gianazza E, Cheroni C, Salmona M, Bendotti C, Bonetto V,. 2005. Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: Possible multifunctional role in the pathogenesis. J Biol Chem 280: 16295-16304.
31. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA,. 2002a. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33: 562-571.
32. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA,. 2002b. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: Dihydropyrimidinase- related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82: 1524-1532.
33. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA,. 2003. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85: 1394-1401.
34. Cenini G, Dowling ALS, Beckett TL, Barone E, Mancuso C, Murphy MP, LeVine H, Lott IT, Schmitt FA, Butterfield DA, Head E,. 2012. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochim Biophys Acta 1822: 130-138.
35. Chavez J, Wu J, Han B, Chung WG, Maier CS,. 2006. New role for an old probe: Affinity labeling of oxylipid protein conjugates by N′- aminooxymethylcarbonylhydrazino D-biotin. Anal Chem 78: 6847-6854.
36. Chavez JD, Bisson WH, Maier CS,. 2010. A targeted mass spectrometry-based approach for the identification and characterization of proteins containing alpha-aminoadipic and gamma-glutamic semialdehyde residues. Anal Bioanal Chem 398: 2905-2914.
37. Chiappetta G, Corbo C, Palmese A, Galli F, Piroddi M, Marino G, Amoresano A,. 2009. Quantitative identification of protein nitration sites. Proteomics 9: 1524-1537.
38. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW,. 2002. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293: 1566-1570.
39. Cini M, Moretti A,. 1995. Studies on lipid peroxidation and protein oxidation in the aging brain. Neurobiol Aging 16: 53-57.
40. Cleveland DW, Rothstein JD,. 2001. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819.
41. Cocciolo A, Di Domenico F, Coccia R, Fiorini A, Cai J, Pierce WM, Mecocci P, Butterfield DA, Perluigi M,. 2012. Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics. Free Radic Biol Med 53: 1868-1876.
42. Codreanu SG, Kim HY, Porter NA, Liebler DC,. 2012. Biotinylated probes for the analysis of protein modification by electrophiles. Methods Mol Biol 803: 77-95.
43. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D,. 1987. Oxygen radicals and human disease. Ann Intern Med 107: 526-545.
44. Dachsel JC, Farrer MJ,. 2010. LRRK2 and Parkinson disease. Arch Neurol 67: 542-547.
45. D'Alessandro A, Rinalducci S, Zolla L,. 2011. Redox proteomics and drug development. J Proteomics 74: 2575-2595.
46. Dalle-Donne I,. 2007. Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis " Free Radic Biol Med 43: 157-159.
47. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A,. 2006a. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10: 389-406.
48. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A,. 2006b. Biomarkers of oxidative damage in human disease. Clin Chem 52: 601-623.
49. Dalle-Donne I, Scaloni A, Butterfield DA,. 2006. Redox proteomics: From protein modification to cellular dysfunction and diseases. Hoboken, NJ: John Wiley & Sons.
50. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A,. 2007. S-glutathionylation in protein redox regulation. Free Radic Biol Med 43: 883-898.
51. Dalle-Donne I, Carini M, Orioli M, Vistoli G, Regazzoni L, Colombo G, Rossi R, Milzani A, Aldini G,. 2009. Protein carbonylation: 2,4- Dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids. Free Radic Biol Med 46: 1411-1419.
52. Di Domenico F, Coccia R, Butterfield DA, Perluigi M,. 2011. Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits. Biochim Biophys Acta 1814: 1785-1795.
53. Di Domenico F, Sultana R, Ferree A, Smith K, Barone E, Perluigi M, Coccia R, Pierce W, Cai J, Mancuso C, Squillace R, Wiengele M, Dalle-Donne I, Wolozin B, Butterfield DA,. 2012. Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: Relevance to Parkinson disease. Antioxid Redox Signal 17: 1490-506.
54. Dogru-Abbasoglu S, Tamer-Toptani S, Ugurnal B, Kocak-Toker N, Aykac-Toker G, Uysal M,. 1997. Lipid peroxidation and antioxidant enzymes in livers and brains of aged rats. Mech Ageing Dev 98: 177-180.
55. Dominguez C, Ruiz E, Gussinye M, Carrascosa A,. 1998. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 21: 1736-1742.
56. Eng J, McCormack A, Yates J,. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5: 976-989.
57. Esterbauer H, Cheeseman KH,. 1990. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421.
58. Esterbauer H, Schaur RJ, Zollner H,. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
59. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Beal MF,. 1997. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 69: 2064-2074.
60. Ferrer I, Martinez A, Blanco R, Dalfo E, Carmona M,. 2011. Neuropathology of sporadic Parkinson disease before the appearance of Parkinsonism: Preclinical Parkinson disease. J Neural Transm 118: 821-839.
61. Fitzmaurice PS, Shaw IC, Kleiner HE, Miller RT, Monks TJ, Lau SS, Mitchell JD, Lynch PG,. 1996. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19: 797-798.
62. Floor E, Wetzel MG,. 1998. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70: 268-275.
63. Fu C, Hu J, Liu T, Ago T, Sadoshima J, Li H,. 2008. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res 7: 3789-3802.
64. Gao XH, Bedhomme M, Veyel D, Zaffagnini M, Lemaire SD,. 2009. Methods for analysis of protein glutathionylation and their application to photosynthetic organisms. Mol Plant 2: 218-235.
65. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, Timms JF,. 2002. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1: 91-98.
66. Ghezzi P, Bonetto V,. 2003. Redox proteomics: Identification of oxidatively modified proteins. Proteomics 3: 1145-1153.
67. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I,. 2004. S-glutathionylation: From redox regulation of protein functions to human diseases. J Cell Mol Med 8: 201-212.
68. Grune T, Reinheckel T, Davies KJ,. 1997. Degradation of oxidized proteins in mammalian cells. FASEB J 11: 526-534.
69. Gurney ME,. 1997. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 152: S67-S73.
70. Hahne H, Neubert P, Kuhn K, Etienne C, Bomgarden R, Rogers JC, Kuster B,. 2012. Carbonyl-reactive tandem mass tags for the proteome-wide quantification of N-linked glycans. Anal Chem 84: 3716-3724.
71. Hang HC, Wilson JP, Charron G,. 2011. Bioorthogonal chemical reporters for analyzing protein lipidation and lipid trafficking. Acc Chem Res 44: 699-708.
72. Haudek VJ, Gundacker NC, Slany A, Wimmer H, Bayer E, Pable K, Gerner C,. 2008. Consequences of acute and chronic oxidative stress upon the expression pattern of proteins in peripheral blood mononuclear cells. J Proteome Res 7: 5138-5147.
73. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K,. 2002. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 51: 2817-2825.
74. Iannello RC, Crack PJ, de Haan JB, Kola I,. 1999. Oxidative stress and neural dysfunction in Down syndrome. J Neural Transm Suppl 57: 257-267.
75. Irazusta V, Moreno-Cermeno A, Cabiscol E, Tamarit J, Ros J,. 2010. Proteomic strategies for the analysis of carbonyl groups on proteins. Curr Protein Pept Sci 11: 652-658.
76. Ishihara K, Amano K, Takaki E, Ebrahim AS, Shimohata A, Shibazaki N, Inoue I, Takaki M, Ueda Y, Sago H, Epstein CJ, Yamakawa K,. 2009. Increased lipid peroxidation in Down's syndrome mouse models. J Neurochem 110: 1965-1976.
77. Jacobs AT, Marnett LJ,. 2010. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res 43: 673-683.
78. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH,. 2001. Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197.
79. Josefsen K, Nielsen SM, Campos A, Seifert T, Hasholt L, Nielsen JE, Norremolle A, Skotte NH, Secher NH, Quistorff B,. 2010. Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiol Dis 40: 656-662.
80. Jovanovic SV, Clements D, MacLeod K,. 1998. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 25: 1044-1048.
81. Junn E, Mouradian MM,. 2002. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320: 146-150.
82. Kanski J, Behring A, Pelling J, Schoneich C,. 2005. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: Effects of biological aging. Am J Physiol Heart Circ Physiol 288: H371-381.
83. Keller JN, Hanni KB, Markesbery WR,. 2000a. Impaired proteasome function in Alzheimer's disease. J Neurochem 75: 436-439.
84. Keller JN, Hanni KB, Markesbery WR,. 2000b. Possible involvement of proteasome inhibition in aging: Implications for oxidative stress. Mech Ageing Dev 113: 61-70.
85. Kim H, Eliuk S, Deshane J, Meleth S, Sanderson T, Pinner A, Robinson G, Wilson L, Kirk M, Barnes S,. 2007. 2D gel proteomics: An approach to study age-related differences in protein abundance or isoform complexity in biological samples. Methods Mol Biol 371: 349-391.
86. Kim HY, Tallman KA, Liebler DC, Porter NA,. 2009. An azido-biotin reagent for use in the isolation of protein adducts of lipid-derived electrophiles by streptavidin catch and photorelease. Mol Cell Proteomics 8: 2080-2089.
87. Kohr MJ, Sun J, Aponte A, Wang G, Gucek M, Murphy E, Steenbergen C,. 2011. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res 108: 418-426.
88. Korchazhkina O, Exley C, Andrew Spencer S,. 2003. Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine. J Chromatogr B Analyt Technol Biomed Life Sci 794: 353-362.
89. Korolainen MA, Pirttila T,. 2009. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease. Acta Neurol Scand 119: 32-38.
90. Korolainen MA, Goldsteins G, Nyman TA, Alafuzoff I, Koistinaho J, Pirttila T,. 2006. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol Aging 27: 42-53.
91. Korolainen MA, Nyman TA, Nyyssonen P, Hartikainen ES, Pirttila T,. 2007. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem 53: 657-665.
92. Kremer B, Weber B, Hayden MR,. 1992. New insights into the clinical-features, pathogenesis and molecular-genetics of Huntington disease. Brain Pathol 2: 321-335.
93. Kumar V, Calamaras TD, Haeussler D, Colucci WS, Cohen RA, McComb ME, Pimentel D, Bachschmid MM,. 2012. Cardiovascular redox and ox stress proteomics. Antioxid Redox Signal 17: 1528-1559.
94. Kurien BT, Dorri Y, Dillon S, Dsouza A, Scofield RH,. 2011. An overview of Western blotting for determining antibody specificities for immunohistochemistry. Methods Mol Biol 717: 55-67.
95. Lallana E, Riguera R, Fernandez-Megia E,. 2011. Reliable and efficient procedures for the conjugation of biomolecules through Huisgen azide-alkyne cycloadditions. Angew Chem Int Ed Engl 50: 8794-8804.
96. Li JY, Popovic N, Brundin P,. 2005. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2: 447-464.
97. Linares Ma, Marín-García P, Méndez Do, Puyet A, Diez A, Bautista JM,. 2011. Proteomic approaches to identifying carbonylated proteins in brain tissue. J Proteome Res 10: 1719-1727.
98. Lindemann C, Leichert LI,. 2012. Quantitative redox proteomics: The NOxICAT method. Methods Mol Biol 893: 387-403.
99. Madian AG, Regnier FE,. 2010a. Profiling carbonylated proteins in human plasma. J Proteome Res 9: 1330-1343.
100. Madian AG, Regnier FE,. 2010b. Proteomic identification of carbonylated proteins and their oxidation sites. J Proteome Res 9: 3766-3780.
101. Madian AG, Diaz-Maldonado N, Gao Q, Regnier FE,. 2011a. Oxidative stress induced carbonylation in human plasma. J Proteomics 74: 2396-2416.
102. Madian AG, Myracle AD, Diaz-Maldonado N, Rochelle NS, Janle EM, Regnier FE,. 2011b. Differential carbonylation of proteins as a function of in vivo oxidative stress. J Proteome Res 10: 3959-3972.
103. Marin-Corral J, Fontes CC, Pascual-Guardia S, Sanchez F, Olivan M, Argiles JM, Busquets S, Lopez-Soriano FJ, Barreiro E,. 2010. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal 12: 365-380.
104. Markesbery WR,. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
105. Markesbery WR, Lovell MA,. 1998. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19: 33-36.
106. Martinez-Acedo P, Nunez E, Sanchez-Gomez FJ, Moreno M, Ramos E, Izquierdo-Alvarez A, Miro-Casas E, Mesa R, Rodriguez P, Martinez-Ruiz A, Garcia-Dorado D, Lamas S, Vazquez J,. 2012. GELSILOX: A novel strategy for global analysis of the dynamic thiol redox proteome. Mol Cell Proteomics 11: 800-813.
107. Matsuyama Y, Terawaki H, Terada T, Era S,. 2009. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Clin Exp Nephrol 13: 308-315.
108. Mecocci P, MacGarvey U, Beal MF,. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747-751.
109. Mirzaei H, Regnier F,. 2005. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal Chem 77: 2386-2392.
110. Mirzaei H, Baena B, Barbas C, Regnier F,. 2008. Identification of oxidized proteins in rat plasma using avidin chromatography and tandem mass spectrometry. Proteomics 8: 1516-1527.
111. Mitrogianni Z, Barbouti A, Galaris D, Siamopoulos KC,. 2004. Tyrosine nitration in plasma proteins from patients undergoing hemodialysis. Am J Kidney Dis 44: 286-292.
112. Miyamoto M,. 1997. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 32: 139-148.
113. Munch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R,. 1997. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35: 669-677.
114. Nagy K, Pollreisz F, Takats Z, Vekey K,. 2004. Atmospheric pressure chemical ionization mass spectrometry of aldehydes in biological matrices. Rapid Commun Mass Spectrom 18: 2473-2478.
115. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, Klein JB, Turner DM, Butterfield DA,. 2007. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res 85: 1506-1514.
116. Niwa T, Naito C, Mawjood AH, Imai K,. 2000. Increased glutathionyl hemoglobin in diabetes mellitus and hyperlipidemia demonstrated by liquid chromatography/electrospray ionization-mass spectrometry. Clin Chem 46: 82-88.
117. Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA,. 2000. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 59: 1011-1017.
118. Odetti P, Angelini G, Dapino D, Zaccheo D, Garibaldi S, Dagna-Bricarelli F, Piombo G, Perry G, Smith M, Traverso N, Tabaton M,. 1998. Early glycoxidation damage in brains from Down's syndrome. Biochem Biophys Res Commun 243: 849-851.
119. Oh-Ishi M, Ueno T, Maeda T,. 2003. Proteomic method detects oxidatively induced protein carbonyls in muscles of a diabetes model Otsuka Long-Evans Tokushima Fatty (OLETF) rat. Free Radic Biol Med 34: 11-22.
120. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA,. 1990. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 87: 5144-5147.
121. Osterman IA, Ustinov AV, Evdokimov DV, Korshun VA, Sergiev PV, Serebryakova MV, Demina IA, Galyamina MA, Govorun VM, Dontsova OA,. 2012. Nascent proteome study by combination of click chemistry and 2D gel electrophoresis. Proteomics 13 (1): 17-21.
122. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B,. 2000. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20: 6048-6054.
123. Palmese A, De Rosa C, Marino G, Amoresano A,. 2011. Dansyl labeling and bidimensional mass spectrometry to investigate protein carbonylation. Rapid Commun Mass Spectrom 25: 223-231.
124. Perez-De La Cruz V, Santamaria A,. 2007. Integrative hypothesis for Huntington's disease: A brief review of experimental evidence. Physiol Res 56: 513-526.
125. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS,. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567.
126. Perluigi M, Butterfield DA,. 2012. Oxidative stress and Down syndrome: A route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res 2012: 724904.
127. Perluigi M, Fai Poon H, Hensley K, Pierce WM, Klein JB, Calabrese V, De Marco C, Butterfield DA,. 2005a. Proteomic analysis of 4-hydroxy-2-nonenal- modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 38: 960-968.
128. Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA,. 2005b. Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: A model of Huntington disease. Mol Cell Proteomics 4: 1849-1861.
129. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, Coccia R, Butterfield DA,. 2009. Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 3: 682-693.
130. Perluigi M, Di Domenico F, Blarzino C, Foppoli C, Cini C, Giorgi A, Grillo C, De Marco F, Butterfield DA, Schinina ME, Coccia R,. 2010a. Effects of UVB-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: A proteomic approach. Proteome Sci 8: 13.
131. Perluigi M, Di Domenico F, Giorgi A, Schinina ME, Coccia R, Cini C, Bellia F, Cambria MT, Cornelius C, Butterfield DA, Calabrese V,. 2010b. Redox proteomics in aging rat brain: Involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res 88: 3498-3507.
132. Perluigi M, di Domenico F, Fiorini A, Cocciolo A, Giorgi A, Foppoli C, Butterfield DA, Giorlandino M, Giorlandino C, Schinina ME, Coccia R,. 2011. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid. Proteomics Clin Appl 5: 167-178.
133. Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, Milner Y, Friguet B,. 2000. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55: B220-B227.
134. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V, Ischiropoulos H, Ohshima H,. 2001. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61: 778-784.
135. Piroddi M, Palmese A, Pilolli F, Amoresano A, Pucci P, Ronco C, Galli F,. 2011. Plasma nitroproteome of kidney disease patients. Amino Acids 40: 653-667.
136. Plowey ED, Cherra SJ III, Liu YJ, Chu CT,. 2008. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105: 1048-1056.
137. Poon HF, Calabrese V, Calvani M, Butterfield DA,. 2006a " Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by L-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress." Antioxid Redox Signal 8: 381-394.
138. Poon HF, Shepherd HM, Reed TT, Calabrese V, Stella AM, Pennisi G, Cai J, Pierce WM, Klein JB, Butterfield DA,. 2006b. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis. Neurobiol Aging 27: 1020-1034.
139. Poon HF, Castegna A, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA,. 2004. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126: 915-926.
140. Poon HF, Farr SA, Banks WA, Pierce WM, Klein JB, Morley JE, Butterfield DA,. 2005a. Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the A beta region of amyloid precursor protein. Mol Brain Res 138: 8-16.
141. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA,. 2005b. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice-A model of familial Parkinson's disease. Neurobiol Dis 18: 492-498.
142. Poon HF, Hensley K, Thongboonkerd V, Merchant ML, Lynn BC, Pierce WM, Klein JB, Calabrese V, Butterfield DA,. 2005c. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 39: 453-462.
143. Poon HF, Vaishnav RA, Butterfield DA, Getchell ML, Getchell TV,. 2005d. Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes. J Neurochem 94: 380-392.
144. Rauniyar N, Prokai L,. 2011. Isotope-coded dimethyl tagging for differential quantification of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation. J Mass Spectrom 46: 976-985.
145. Rauniyar N, Prokai-Tatrai K, Prokai L,. 2010. Identification of carbonylation sites in apomyoglobin after exposure to 4-hydroxy-2-nonenal by solid-phase enrichment and liquid chromatography-electrospray ionization tandem mass spectrometry. J Mass Spectrom 45: 398-410.
146. Reed TT,. 2011. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 51: 1302-1319.
147. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA,. 2008. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30: 107-120.
148. Reed TT, Pierce WM, Jr., Turner DM, Markesbery WR, Butterfield DA,. 2009a. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J Cell Mol Med 13: 2019-2029.
149. Reed TT, Pierce WM, Markesbery WR, Butterfield DA,. 2009b. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res 1274: 66-76.
150. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB,. 2010. Oxidative stress, inflammation, and cancer: How are they linked ? Free Radic Biol Med 49: 1603-1616.
151. Robinson RA, Evans AR,. 2012. Enhanced sample multiplexing for nitrotyrosine-modified proteins using combined precursor isotopic labeling and isobaric tagging. Anal Chem 84: 4677-4686.
152. Robinson RA, Lange MB, Sultana R, Galvan V, Fombonne J, Gorostiza O, Zhang J, Warrier G, Cai J, Pierce WM, Bredesen DE, Butterfield DA,. 2011. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: Effects of the amyloid-beta peptide of amyloid precursor protein. Neuroscience 177: 207-222.
153. Roe MR, Griffin TJ,. 2006. Gel-free mass spectrometry-based high
154. Roe MR, Xie H, Bandhakavi S, Griffin TJ,. 2007. Proteomic mapping of 4-hydroxynonenal protein modification sites by solid-phase hydrazide chemistry and mass spectrometry. Anal Chem 79: 3747-3756.
155. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ,. 2004. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
156. Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, Ghosh J, Hsu CH, Segal L, Raghavan K, Matsumoto K, Hisamoto N, Kuwahara T, Iwatsubo T, Moore L, Goldstein L, Cookson M, Wolozin B,. 2009. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29: 9210-9218.
157. Schopfer FJ, Baker PR, Freeman BA,. 2003. NO-dependent protein nitration: A cell signaling event or an oxidative inflammatory response ? Trends Biochem Sci 28: 646-654.
158. Scibior-Bentkowska D, Czeczot H,. 2009. [Cancer cells and oxidative stress]. Postepy Hig Med Dosw (Online) 63: 58-72.
159. Shacter E, Williams JA, Lim M, Levine RL,. 1994. Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassay. Free Radic Biol Med 17: 429-437.
160. Shao CH, Capek HL, Patel KP, Wang M, Tang K, DeSouza C, Nagai R, Mayhan W, Periasamy M, Bidasee KR,. 2011. Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes. Diabetes 60: 947-959.
161. Shaw PJ, Ince PG, Falkous G, Mantle D,. 1995. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 38: 691-695.
162. Sheehan D,. 2006. Detection of redox-based modification in two-dimensional electrophoresis proteomic separations. Biochem Biophys Res Commun 349: 455-462.
163. Sheehan D, McDonagh B, Barcena JA,. 2010. Redox proteomics. Expert Rev Proteomics 7: 1-4.
164. Shibata N, Nagai R, Uchida K, Horiuchi S, Yamada S, Hirano A, Kawaguchi M, Yamamoto T, Sasaki S, Kobayashi M,. 2001. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 917: 97-104.
165. Slade PG, Williams MV, Brahmbhatt V, Dash A, Wishnok JS, Tannenbaum SR,. 2010. Proteins modified by the lipid peroxidation aldehyde 9,12-dioxo-10(E)- dodecenoic acid in MCF7 breast cancer cells. Chem Res Toxicol 23: 557-567.
166. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G,. 1997. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17: 2653-2657.
167. Snell RG, Macmillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, Macdonald ME, Gusella JF, Harper PS, Shaw DJ,. 1993. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 4: 393-397.
168. Soderling AS, Ryberg H, Gabrielsson A, Larstad M, Toren K, Niari S, Caidahl K,. 2003. A derivatization assay using gas chromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J Mass Spectrom 38: 1187-1196.
169. Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E,. 2008. Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 45: 667-678.
170. Sorolla MA, Rodriguez-Colman MJ, Tamarit J, Ortega Z, Lucas JJ, Ferrer I, Ros J, Cabiscol E,. 2010. Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic Biol Med 49: 612-621.
171. Stadtman ER, Berlett BS,. 1998. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30: 225-243.
172. Stadtman ER, Levine RL,. 2003. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25: 207-218.
173. Stadtman ER, Oliver CN, Levine RL, Fucci L, Rivett AJ,. 1988. Implication of protein oxidation in protein turnover, aging, and oxygen toxicity. Basic Life Sci 49: 331-339.
174. Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA,. 1997. The lipid peroxidation product, 4-hydroxy-2-trans- nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 69: 1161-1169.
175. Sultana R, Butterfield DA,. 2009. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol Biol 566: 123-135.
176. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Markesbery WR, Zhou XZ, Lu KP, Butterfield DA,. 2006a. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 27: 918-925.
177. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA,. 2006b. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27: 1564-1576.
178. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA,. 2006c. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22: 76-87.
179. Sultana R, Reed T, Perluigi M, Coccia R, Pierce WM, Butterfield DA,. 2007. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: A regional study. J Cell Mol Med 11: 839-851.
180. Sultana R, Perluigi M, Newman SF, Pierce WM, Cini C, Coccia R, Butterfield DA,. 2010. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 12: 327-336.
181. Sultana R, Perluigi M, Allan Butterfield D,. 2012. Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med (in press).
182. Szweda PA, Friguet B, Szweda LI,. 2002. Proteolysis, free radicals, and aging. Free Radic Biol Med 33: 29-36.
183. Tabner BJ, El-Agnaf OM, German MJ, Fullwood NJ, Allsop D,. 2005. Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem Soc Trans 33: 1082-1086.
184. Thongboonkerd V, Malasit P,. 2005. Renal and urinary proteomics: Current applications and challenges. Proteomics 5: 1033-1042.
185. Timms JF, Cramer R,. 2008. Difference gel electrophoresis. Proteomics 8: 4886-4897.
186. Tsaytler PA, M COF, Sakharov DV, Krijgsveld J, Egmond MR,. 2008. Immediate protein targets of photodynamic treatment in carcinoma cells. J Proteome Res 7: 3868-3878.
187. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A,. 2003. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60: 307-314.
188. Turner C, Schapira AH,. 2010. Mitochondrial matters of the brain: The role in Huntington's disease. J Bioenerg Biomembr 42: 193-198.
189. Tyther R, Ahmeda A, Johns E, Sheehan D,. 2007. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics 7: 4555-4564.
190. Tyther R, Ahmeda A, Johns E, McDonagh B, Sheehan D,. 2010. Proteomic profiling of perturbed protein sulfenation in renal medulla of the spontaneously hypertensive rat. J Proteome Res 9: 2678-2687.
191. Unlu M, Morgan ME, Minden JS,. 1997. Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 18: 2071-2077.
192. Van Laar VS, Dukes AA, Cascio M, Hastings TG,. 2008. Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: Implications for Parkinson disease. Neurobiol Dis 29: 477-489.
193. Varadarajan S, Yatin S, Aksenova M, Butterfield DA,. 2000. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130: 184-208.
194. Victor KG, Rady JM, Cross JV, Templeton DJ,. 2012. Proteomic profile of reversible protein oxidation using PROP, purification of reversibly oxidized proteins. PLoS ONE 7: e32527.
195. Vila A, Tallman KA, Jacobs AT, Liebler DC, Porter NA, Marnett LJ,. 2008. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem Res Toxicol 21: 432-444.
196. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A,. 1994. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91: 4766-4770.
197. Wilson CH, Zeile S, Chataway T, Nieuwenhuijs VB, Padbury RT, Barritt GJ,. 2011. Increased expression of peroxiredoxin 1 and identification of a novel lipid-metabolizing enzyme in the early phase of liver ischemia reperfusion injury. Proteomics 11: 4385-4396.
198. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B,. 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313.
199. Wittmann-Liebold B, Graack HR, Pohl T,. 2006. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6: 4688-4703.
200. Wu CL, Chou HC, Cheng CS, Li JM, Lin ST, Chen YW, Chan HL,. 2012. Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J Proteomics 75: 1991-2014.
201. Yagi H, Katoh S, Akiguchi I, Takeda T,. 1988. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res 474: 86-93.
202. Yan LJ, Forster MJ,. 2011. Chemical probes for analysis of carbonylated proteins: A review. J Chromatogr B Analyt Technol Biomed Life Sci 879: 1308-1315.
203. Yeo WS, Lee SJ, Lee JR, Kim KP,. 2008. Nitrosative protein tyrosine modifications: Biochemistry and functional significance. BMB Rep 41: 194-203.
204. Ying J, Clavreul N, Sethuraman M, Adachi T, Cohen RA,. 2007. Thiol oxidation in signaling and response to stress: Detection and quantification of physiological and pathophysiological thiol modifications. Free Radic Biol Med 43: 1099-1108.
205. Yoo BS, Regnier FE,. 2004. Proteomic analysis of carbonylated proteins in two-dimensional gel electrophoresis using avidin-fluorescein affinity staining. Electrophoresis 25: 1334-1341.
206. Yorek MA,. 2003. The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 37: 471-480.
207. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y,. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93: 2696-2701.
208. Yu HL, Chertkow HM, Bergman H, Schipper HM,. 2003. Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics 3: 2240-2248.
209. Zhu Y, Carvey PM, Ling Z,. 2006. Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res 1090: 35-44.